Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Change In Receivables?

Shijiazhuang Yiling Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Shijiazhuang Yiling Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shijiazhuang Yiling Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-700 Mil. It means Shijiazhuang Yiling Pharmaceutical Co's Accounts Receivable increased by ¥700 Mil from Dec. 2022 to Dec. 2023 .

Shijiazhuang Yiling Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥2,563 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shijiazhuang Yiling Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 92.72.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shijiazhuang Yiling Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥-1,163 Mil.

Shijiazhuang Yiling Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Change In Receivables Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-800.37

-668.73

-1,280.28

-831.66

-700.49

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shijiazhuang Yiling Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shijiazhuang Yiling Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2563.254	/	2522.633	*	91
=	92.72

2. In Ben Graham's calculation of liquidation value, Shijiazhuang Yiling Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Shijiazhuang Yiling Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1303.163	-	5388.589	+	0.75 * 2563.254	+	0.5 * 2000.817
=	-1,163

Shijiazhuang Yiling Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN

Website

http://www.yiling.cn/

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.

Executives

Zhang Qiu Lian	Directors, executives
Han Yue Zhi	Executives
Zhao Shao Hua	Executives
Wang Wei	Executives
Gao Xue Dong	Supervisors
Wu Yi Ling	Director
Gao Xiu Qiang	Executives
Wu Xiang Jun	Directors, executives
Guo Shuang Geng	Director
Wang Hua	Securities Affairs Representative
Dai Feng Xiang	Directors, executives
Liu Gen Wu	Supervisors
Wang Wei Ping	Directors, executives
Xu Wei Dong	Director
Wu Rui	Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines